{"ticker": {"uuid": "88a42955-fbd8-4b99-a43b-7a876c181d46", "symbol": "ALZCUR", "name": "AlzeCure Pharma AB (publ)", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "AlzeCure shares hit highest since 2022 on $2.2 bln Alzheimer\u2019s drug licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOSHh3UVB6MUhGOUJwczFrYXVSZ0FFMzdPM293N3V5ZF9YaVNUU182YWlTeXQwd3lFeFI0ZElFcTcwNWlyeGtqYXM3a0pGWEFNcWhGQVFVMExsaHYwS2ZQbHR5RDVWTUZSSmRCeWxKdHdObVl2dEZ1c2lCaU95NlUyU1JCY0tSOC1CY2ZuaFRnbld6dG5JbFMwRmVCdEpySkFGbko0dlc2dE1Uc0JiYXlLal9wbDhZOVVLRVNkMkh1bGk4aW1ZZVhhNGhBb1poVm45?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-01T07:46:29+00:00", "published_display": "01 Jul 2026 07:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Final outcome of AlzeCure\u2019s rights issue", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQU1pKUHpfc0xldkNKXzB1cnJESnQ5S2p2WV96M1B1Ym82ekRoNEtENGZvbWppYmVTSF84UWhHZWo5eVZrVmx6MHFlQlo3V2NsYVg0c2Y4dXF3VWNLNWt6N3ZqaHh5bTJpODltNk5qaG9wYU1KVjVUWFhob1BQM25EVW8weHRjSTY2OFdlSjhfczJCeEpCUW5QTU9sVDBYTUJTWGxwOHdWQjRUQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The subscription period in AlzeCure Pharma's Rights Issue begins today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQanN1WVIzNkZoSFRILWUxYmdZaFVsaFh2MEtXLUxMMFlyakFuc0FOQ0pCQUVxYXRfUW5odHJJcU1OMXZwSWRUSkItM3dlQ283VjZERlpzZEFNdGRneXJuamhzT1pkOVBRVE45NDBvRWdrWk5JTFlPX24wekZQSlliWFBmaG4wZDVpTkhWVklCZHNfR2kxWTFxcS1KQnBpRGRIWHUzZ2kwLV9DR1hVandwVm1odzA2RGU0QjEtYkR1VVNKSjA5V2V3WXp4V3FwckFrdGc?oc=5", "source_name": "TradingView", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma (ALZCUR) Stock Surges 301% After Eli Lilly Alzheimer\u2019s Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOb0QzM2JWV1hiWV9VTXVvMHNvQk40WDRLbUdEUjMzNGRGck9DM1lmVWVreTdNbk5yaFJ4ak9sU1JuUGpTUW9FYmFWN2hUMVJLUHFfZzlvVjh4Um54UGxHODd2RlByeDg5QXR1cElVVHNKSUtfSmZRWDFHeDFfMGNjNGNqV0NsSTlyVVU1eWh4dFdJR2l6aDQ1Mmgybkk?oc=5", "source_name": "CoinCentral", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma stock surges 301% on Eli Lilly deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYkthSy0yQ2N0RHZqTVRIdzFLcTJhanhpMG1MR2NvVGs4QTUtMnZEOVlYbzl6bE1YSlJIQmtLWFZCMnloT1hteUpIR2k5cVRTZnpCWUY1eGJZV2hiQ0dyTTlMTktPUUZwQlpDOW12aHM4eDBrVm8xX1c2b1phUWloZ1ZJS3ppVFhRdkFhMDZjckV0cFpfd3BKMDZkLTBzVGNvMEdDOWNVRVlKNWc?oc=5", "source_name": "Investing.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's Project", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQSC10QWd1NmJRWUNtZTQ0ekE5SU5uMUsyNU1UN18tNFdoUmlzQmJxSVphanh6a2ZaTUdrVFdheWsxeFV6dFpSYTZEMXdnTDJ6bGxMS1hWMmRabmptRzdLT2lRWGQzdkRKcVJydWVfcWNMbDJBaGdBQmx6S3ltd21XR1NLZ3RrR0I2WGVRV1RkT2Nha0dvaVU4R1BfYWpWSWV5dGhMcWxGRk5rUGI5TzBxMkg5OTZzZw?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma exponential on Eli Lilly licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNUDkzSlN3cVl0Z1VHakVuS1NjdU9WSlp3T2RWMW9DY0Z4LTJrS3NFYWNZTXFzTkVJd2tVamNnS2w4bGM4YklIUmxFb1ZUYWQ4N1NUcGRpLUQtZFBSY3hLZTZNSVFMN2x0QzhuZTdhWU9VYWpTdVNPSHc4WXNUcTh2Q2Etdk5DOUZubmJTdTFtUkhxV1V4VXU2cFBCeVhENFJpUE04bk5tWUZfdWgt?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma (ALZCUR) Stock Jumps Over 300% on Eli Lilly Partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOYXFSRDRmbWd1UDI3a0Vqa01iQ183ZWFqOWRfbUpzQ3plQXEtWkVKcmNNZDMyU0dBRVB0ZFJ2bVFFcmlwYmxLTnRWenR3X3NoaTNNcVNCR0ZkamJqREx3Nzg1dW9GMUxIc1M0aHNoUXFucjl3enFFbEE0bFJ1cFhQQWZOaTl1UHRkOF9fRlItaUxZSExlbGtB?oc=5", "source_name": "Blockonomi", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma (ALZCUR) Stock Soars 301% Following Eli Lilly Partnership Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNSUdFUUZ2c3RyUG9IZ3VsRmlUdGpQU1k5bGNqOG9hTjMxLVJOOWsxMFd1QVoxc25GdkR2dU5kZEE1aEhDME5GMFpfdlh2cFpxR2V3WUVSejRLeFhTUW9EQk01dzNXT2FGb1BKTm1DSGNEOW16djZPUGdMNWVfM2dST3lkRUJkYl9FV2FoQm1CYnlfRzhvVlMxTmY1QmFBZw?oc=5", "source_name": "parameter.io", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AlzeCure shares hit highest since 2022 on $2.2 bln Alzheimer\u2019s drug licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOSHh3UVB6MUhGOUJwczFrYXVSZ0FFMzdPM293N3V5ZF9YaVNUU182YWlTeXQwd3lFeFI0ZElFcTcwNWlyeGtqYXM3a0pGWEFNcWhGQVFVMExsaHYwS2ZQbHR5RDVWTUZSSmRCeWxKdHdObVl2dEZ1c2lCaU95NlUyU1JCY0tSOC1CY2ZuaFRnbld6dG5JbFMwRmVCdEpySkFGbko0dlc2dE1Uc0JiYXlLal9wbDhZOVVLRVNkMkh1bGk4aW1ZZVhhNGhBb1poVm45?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-01T07:46:29+00:00", "published_display": "01 Jul 2026 07:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Final outcome of AlzeCure\u2019s rights issue", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQU1pKUHpfc0xldkNKXzB1cnJESnQ5S2p2WV96M1B1Ym82ekRoNEtENGZvbWppYmVTSF84UWhHZWo5eVZrVmx6MHFlQlo3V2NsYVg0c2Y4dXF3VWNLNWt6N3ZqaHh5bTJpODltNk5qaG9wYU1KVjVUWFhob1BQM25EVW8weHRjSTY2OFdlSjhfczJCeEpCUW5QTU9sVDBYTUJTWGxwOHdWQjRUQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The subscription period in AlzeCure Pharma's Rights Issue begins today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQanN1WVIzNkZoSFRILWUxYmdZaFVsaFh2MEtXLUxMMFlyakFuc0FOQ0pCQUVxYXRfUW5odHJJcU1OMXZwSWRUSkItM3dlQ283VjZERlpzZEFNdGRneXJuamhzT1pkOVBRVE45NDBvRWdrWk5JTFlPX24wekZQSlliWFBmaG4wZDVpTkhWVklCZHNfR2kxWTFxcS1KQnBpRGRIWHUzZ2kwLV9DR1hVandwVm1odzA2RGU0QjEtYkR1VVNKSjA5V2V3WXp4V3FwckFrdGc?oc=5", "source_name": "TradingView", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma (ALZCUR) Stock Surges 301% After Eli Lilly Alzheimer\u2019s Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOb0QzM2JWV1hiWV9VTXVvMHNvQk40WDRLbUdEUjMzNGRGck9DM1lmVWVreTdNbk5yaFJ4ak9sU1JuUGpTUW9FYmFWN2hUMVJLUHFfZzlvVjh4Um54UGxHODd2RlByeDg5QXR1cElVVHNKSUtfSmZRWDFHeDFfMGNjNGNqV0NsSTlyVVU1eWh4dFdJR2l6aDQ1Mmgybkk?oc=5", "source_name": "CoinCentral", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma stock surges 301% on Eli Lilly deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYkthSy0yQ2N0RHZqTVRIdzFLcTJhanhpMG1MR2NvVGs4QTUtMnZEOVlYbzl6bE1YSlJIQmtLWFZCMnloT1hteUpIR2k5cVRTZnpCWUY1eGJZV2hiQ0dyTTlMTktPUUZwQlpDOW12aHM4eDBrVm8xX1c2b1phUWloZ1ZJS3ppVFhRdkFhMDZjckV0cFpfd3BKMDZkLTBzVGNvMEdDOWNVRVlKNWc?oc=5", "source_name": "Investing.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's Project", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQSC10QWd1NmJRWUNtZTQ0ekE5SU5uMUsyNU1UN18tNFdoUmlzQmJxSVphanh6a2ZaTUdrVFdheWsxeFV6dFpSYTZEMXdnTDJ6bGxMS1hWMmRabmptRzdLT2lRWGQzdkRKcVJydWVfcWNMbDJBaGdBQmx6S3ltd21XR1NLZ3RrR0I2WGVRV1RkT2Nha0dvaVU4R1BfYWpWSWV5dGhMcWxGRk5rUGI5TzBxMkg5OTZzZw?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma exponential on Eli Lilly licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNUDkzSlN3cVl0Z1VHakVuS1NjdU9WSlp3T2RWMW9DY0Z4LTJrS3NFYWNZTXFzTkVJd2tVamNnS2w4bGM4YklIUmxFb1ZUYWQ4N1NUcGRpLUQtZFBSY3hLZTZNSVFMN2x0QzhuZTdhWU9VYWpTdVNPSHc4WXNUcTh2Q2Etdk5DOUZubmJTdTFtUkhxV1V4VXU2cFBCeVhENFJpUE04bk5tWUZfdWgt?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma (ALZCUR) Stock Jumps Over 300% on Eli Lilly Partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOYXFSRDRmbWd1UDI3a0Vqa01iQ183ZWFqOWRfbUpzQ3plQXEtWkVKcmNNZDMyU0dBRVB0ZFJ2bVFFcmlwYmxLTnRWenR3X3NoaTNNcVNCR0ZkamJqREx3Nzg1dW9GMUxIc1M0aHNoUXFucjl3enFFbEE0bFJ1cFhQQWZOaTl1UHRkOF9fRlItaUxZSExlbGtB?oc=5", "source_name": "Blockonomi", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AlzeCure Pharma (ALZCUR) Stock Soars 301% Following Eli Lilly Partnership Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNSUdFUUZ2c3RyUG9IZ3VsRmlUdGpQU1k5bGNqOG9hTjMxLVJOOWsxMFd1QVoxc25GdkR2dU5kZEE1aEhDME5GMFpfdlh2cFpxR2V3WUVSejRLeFhTUW9EQk01dzNXT2FGb1BKTm1DSGNEOW16djZPUGdMNWVfM2dST3lkRUJkYl9FV2FoQm1CYnlfRzhvVlMxTmY1QmFBZw?oc=5", "source_name": "parameter.io", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 61, "total_relevant": 9, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 7, "score": 54, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 81, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 3.3, "count": 6}, {"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 6.16, "latest_week": "2026-07-10", "one_week_move": -19.6, "four_week_move": 43.9, "twelve_week_move": 335.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.606812, "market_dynamics_buy_signal": false, "relative_strength": 122.63543, "fair_value_gap": 141.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 49.789, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-19.6% over one week, +43.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "CoinCentral", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "Market source", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "Blockonomi", "count": 1}, {"label": "parameter.io", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 6}, {"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-19.6% over one week, +43.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "AlzeCure shares hit highest since 2022 on $2.2 bln Alzheimer\u2019s drug licensing deal"}], "updated_at": "2026-07-17T23:17:31.449935+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}